Behavioral Health Business May 1, 2024
Prescription digital therapeutics company Akili, Inc. (Nasdaq: AKLI) announced another workforce reduction, terminating nearly half of its remaining employees.
The layoffs, which amount to 46% of Akili’s workforce, will eliminate the company’s marketing and medical affairs teams, according to publicly available documents. The restructuring, which is estimated to cost between $2.3 and $2.8 million including severance costs, is expected to be completed by the end of the second quarter of 2024.
This is the company’s third round of significant layoffs in less than a year and a half.
In September 2023, Akili announced it would lay off 40% of its staff, primarily in its field sales force and market access teams.
In January 2023, the company made plans...
Today's Sponsors
Today's Sponsor